Exelixis
EXEL
#1649
Rank
NZ$22.92 B
Marketcap
NZ$91.19
Share price
-0.24%
Change (1 day)
32.13%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Cost to borrow EXEL shares - Exelixis

Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.4081% (annualized)

Shares available to borrow: 3600000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Exelixis (EXEL) - cost to borrow in the last 7 days chart

Exelixis (EXEL) - number of shares available to borrow in the last 7 days

Exelixis (EXEL) - cost to borrow from 2026 to 2023

Exelixis (EXEL) - number of shares available to borrow from 2026 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
Johnson & Johnson
JNJ
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0.2651%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
0.2734%5.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
0.2674%2.9 M๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
0.2685%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
0.4027%0.65 M๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
3.0682%1.2 M๐Ÿ‡บ๐Ÿ‡ธ USA